2014/3 GaBI Journal Table of Contents

Published in: Volume 3 / Year 2014 / Issue 3
Category: 2014/3 GaBI Journal Table of Contents
Visits: 2669 total, 2 today

Contents

Editor’s Letter

Latest features in GaBI Journal, 2014, Issue 3

Editorial

Regional regulatory processes for the approval of biosimilars; differences and similarities

Original Research

Barriers to market uptake of biosimilars in the US

Retrospective chart review: disrupted anaemia control in haemodialysis patients following the switch to an iron sucrose similar (ISS) after long-term treatment with the originator iron sucrose (IS)

Ongoing initiatives to improve prescribing efficiency in China; statins as a case history

GnRH agonists and antagonists in prostate cancer

Review Article

Recommendations for the regulation of biosimilars and their implementation in Latin America

Perspective

Subsequent entry biologics (biosimilars) in Canada: approaches to interchangeability and the extrapolation of indications and uses

Interview

Biosimilars collaboration at Amgen and Actavis

Pharma News

ECCO 2013 survey highlights lack of confidence in biosimilars

Go Back Print

Leave a Reply